Agnaldo Anelli

Tamoxifen adminstration is associated with a high rate of treatment‐limiting symptoms in male breast cancer patients

Tânia F. Moredo Anelli, Agnaldo Anelli, Katherine N. Tran et al. · Cancer · 1994 · 179 citations

Mutations of the p53 gene in male breast cancer

Agnaldo Anelli, T nia F. M. Anelli, Bruce Youngson et al. · Cancer · 1995 · 77 citations · Full text

Final results of a randomized controlled phase III trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F) to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC)

Vladimir Moiseyenko, Jaffer A. Ajani, S. Tjulandin et al. · Journal of Clinical Oncology · 2005 · 73 citations

Tcf Benefit/risk Ratio, Surgical Oncology, Weight Loss +14

Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer

Agnaldo Anelli, Andréa Gadelha, A. Amorim de Albuquerque et al. · Annals of Oncology · 2003 · 47 citations

P53 Status, Breast Oncology, Medicine +7

A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: sustained efficiency and simplified administration

Artur Katz, Sidnei Epelman, Agnaldo Anelli et al. · Journal of Cancer Research and Clinical Oncology · 1995 · 31 citations · Full text

Ifosfamide-containing Chemotherapy Regimen, Medicine, Metronomic Therapy +8